瘤学:你可能在2024年错过了什么
Zainab Ali Amer Al Maqrashi1, Sze Wah Samuel Chan1, Zeba Siddiqui1
1Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, Ontario, Canada (Z.A.A.A.M., S.W.S.C., Z.S.).
Annals of internal medicine
|March 31, 2025
概括
内科医生在癌症护理中发挥着关键作用,从查到监测. 具有里程碑意义的2024年研究揭示了免疫疗法,向疗法和支持性护理的进步,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 内部医学 内部医学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 50多年来,瘤学取得了重大进展,影响了癌症患者的护理.
- 内部医学医生在患者的癌症过程中是不可或缺的,从初始查到长期监测.
研究的目的:
- 审查从2024年起在瘤学中进行的10项里程碑式研究.
- 突出癌症治疗中的新兴疗法和不断变化的临床标准.
- 强调内部医学在管理复杂的癌症护理中的作用.
主要方法:
- 对2024年发表的10项具有里程碑意义的瘤学研究的综述.
- 分析新兴疗法,包括免疫疗法,向疗法和抗体药物合物.
- 评估支持性护理和症状管理方面的进展.
主要成果:
- 免疫疗法,特别是检查点抑制剂,正在扩大其在各种阶段的固体瘤中的应用.
- 向疗法和抗体-药物合物为转移性癌症提供了更高的精度治疗.
- 支持性护理创新,如MRI导向前列腺查和缓解和疼痛的药物,改善了患者的生活质量.
结论:
- 内科医生在多学科的癌症护理中至关重要,共同管理患者和监测治疗毒性.
- 保持与新瘤疗法保持一致对于内部医学医生来说至关重要,以优化患者护理和结果.
- 癌症治疗的最新进展强调了整合新疗法的重要性,同时有效地管理它们的挑战.
更多相关视频
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
75
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Vaccines
313
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
313
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
